1-(4-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzoyl)piperidine-2-carboxylic acid

ID: ALA4584953

PubChem CID: 155562260

Max Phase: Preclinical

Molecular Formula: C20H21N5O4

Molecular Weight: 395.42

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nc2[nH]cc(Cc3ccc(C(=O)N4CCCCC4C(=O)O)cc3)c2c(=O)[nH]1

Standard InChI:  InChI=1S/C20H21N5O4/c21-20-23-16-15(17(26)24-20)13(10-22-16)9-11-4-6-12(7-5-11)18(27)25-8-2-1-3-14(25)19(28)29/h4-7,10,14H,1-3,8-9H2,(H,28,29)(H4,21,22,23,24,26)

Standard InChI Key:  MSVUEWKJQGSLKC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    3.3596  -11.7378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3596  -12.5550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0648  -12.9595    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0648  -11.3251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7701  -11.7378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7746  -12.5515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5498  -12.7987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0245  -12.1378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5426  -11.4822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0648  -10.5079    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6524  -12.9647    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7908  -10.7037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5892  -10.5294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1359  -11.1371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9336  -10.9633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1826  -10.1841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6276   -9.5784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8320   -9.7554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9807  -10.0087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5317  -10.6122    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2279   -9.2298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0268   -9.0603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2748   -8.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7268   -7.6787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9273   -7.8524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6758   -8.6327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5750   -9.6668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3241  -10.4445    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3740   -9.4953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  2  0
  2 11  1  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 27 28  1  0
 27 29  2  0
 22 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4584953

    ---

Associated Targets(Human)

TYMS Tclin Thymidylate synthase (1651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bifunctional dihydrofolate reductase-thymidylate synthase (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 395.42Molecular Weight (Monoisotopic): 395.1594AlogP: 1.50#Rotatable Bonds: 4
Polar Surface Area: 145.17Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 3.86CX Basic pKa: 3.18CX LogP: 1.05CX LogD: -1.70
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -0.46

References

1. Czyzyk DJ, Valhondo M, Deiana L, Tirado-Rives J, Jorgensen WL, Anderson KS..  (2019)  Structure activity relationship towards design of cryptosporidium specific thymidylate synthase inhibitors.,  183  [PMID:31536894] [10.1016/j.ejmech.2019.111673]

Source